Mereo BioPharma Group plc
For the period ended Jun 30, 2026. Filed Aug 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 11, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Legal Proceedings
Item 1. Legal Proceedings
The information set forth in Note 15, Commitments and contingencies, to the condensed consolidated financial statements included elsewhere in this Quarterly Report under the caption “Legal Proceedings” is incorporated herein by reference.
There have been no material developments in such proceedings during the quarter ended June 30, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.